Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

Triple-negative breast cancer (TNBC) is the most refractory subtype of breast cancer. It causes the majority of breast cancer-related deaths, which has been largely associated with the plasticity of tumor cells and persistence of cancer stem cells (CSCs). Conventional chemotherapeutics enrich CSCs a...

Descripción completa

Detalles Bibliográficos
Autores principales: Sulaiman, Andrew, McGarry, Sarah, Lam, Ka Mien, El-Sahli, Sara, Chambers, Jason, Kaczmarek, Shelby, Li, Li, Addison, Christina, Dimitroulakos, Jim, Arnaout, Angel, Nessim, Carolyn, Yao, Zemin, Ji, Guang, Song, Haiyan, Liu, Sheng, Xie, Ying, Gadde, Suresh, Li, Xuguang, Wang, Lisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062597/
https://www.ncbi.nlm.nih.gov/pubmed/30050079
http://dx.doi.org/10.1038/s41419-018-0811-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062597/
https://www.ncbi.nlm.nih.gov/pubmed/30050079
http://dx.doi.org/10.1038/s41419-018-0811-7

Ejemplares similares